Abstract
The aim of this study was to investigate the possible association between the functional polymorphism in the upstream regulatory region of the serotonin transporter gene (5-HTTLPR) and the prophylactic efficacy of lithium in mood disorders. Two hundred and one subjects affected by bipolar (n = 167) and major depressive (n = 34) disorder were followed prospectively for an average of 58.2 months and were typed for their 5-HTTLPR variant using polymerase chain reaction techniques. 5-HTTLPR variants were associated with lithium outcome (F = 5.35; df = 2,198; P = 0.005). Subjects with the s/s variant showed a worse response compared to both l/s and l/l variants. Consideration of possible stratification effects such as sex, polarity, age at onset, duration of lithium treatment and previous episodes did not influence the observed association. 5-HTTLPR variants may be a possible influencing factor for the prophylactic efficacy of lithium in mood disorders.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 6 print issues and online access
$259.00 per year
only $43.17 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Goodwin F, Jamison K . Manic-Depressive Illness Oxford University Press: New York 1990
Schou M . Lithium Treatment of Manic Depressive Illness. A Practical Guide Karger: Basel 1989
Maj M, Arena F, Lovero N, Pirozzi R, Kemali D . Factors associated with response to lithium prophylaxis in DSM III major depression and bipolar disorder Pharmacopsychiatry 1985 18: 309–313
Maj M, Pirozzi R, Starace F . Previous pattern of course of the illness as a predictor of response to lithium prophylaxis in bipolar patients J Affect Disord 1989 17: 237–241
OConnell RA, Mayo JA, Flatow L, Cuthbertson BO, Brien BE . Outcome of bipolar disorder on long-term treatment with lithium Br J Psychiatry 1991 159: 123–129
Abou-Saleh MT . Who responds to prophylactic lithium therapy? Br J Psychiatry 1993 (suppl 21): 20–26
Franchini L, Zanardi R, Smeraldi E, Gasperini M . Early onset of lithium prophylaxis as a predictor of good long-term outcome Eur Arch Psychiatry Clin Neurosci 1999 249: 227–230
Serretti A, Lattuada E, Franchini L, Smeraldi E . Melancholic features and response to lithium prophylaxis in mood disorders Depress Anxiety 2000 11: 73–79
Mendlewicz J, Fieve RR, Stallone F, Fleiss JL . Genetic history as a predictor of lithium response in manic-depressive illness Lancet 1972 1: 599–600
Maj M, Del Vecchio M, Starace F, Pirozzi R, Kemali D . Prediction of affective psychoses response to lithium prophylaxis. The role of socio-demographic, clinical, psychological and biological variables Acta Psychiatr Scand 1984 69: 37–44
Grof P, Alda M, Grof E, Zvolsky P, Walsh M . Lithium response and genetics of affective disorders J Affect Disord 1994 32: 85–95
Morabito A, Gasperini M, Macciardi F, Smeraldi E . Possible relationship between outcome in primary affective disorders treated with lithium and family history Adv Biochem Psychopharmacol 1982 32: 157–163
Smeraldi E, Petroccione A, Gasperini M, Macciardi F, Orsini A . The search for genetic homogeneity in affective disorders J Affect Disord 1984 7: 99–107
Smeraldi E, Petroccione A, Gasperini M, Macciardi F, Orsini A, Kidd KK . Outcomes on lithium treatment as a tool for genetic studies in affective disorders J Affect Disord 1984 6: 139–151
Cavazzoni P, Alda M, Turecki G, Rouleau G, Grof E, Gerlach JH et al . Lithium-responsive affective disorders: no association with the tyrosine hydroxylase gene Psychiatry Res 1996 64: 91–96
Turecki G, Alda M, Grof P, Martin R, Cavazzoni PA, Gerlach JH et al . No association between chromosome-18 markers and lithium-responsive affective disorders Psychiatry Res 1996 63: 17–23
Belmaker RH, Bersudsky Y, Agam G, Levine J, Kofman O . How does lithium work on manic depression? Clinical and psychological correlates of the inositol theory Annu Rev Med 1996 47: 47–56
El-Mallakh S . Lithum: Actions and Mechanisms American Psychiatric Press: Washington, DC 1996
Benkelfat C . Serotoninergic mechanisms in psychiatric disorders: new research tools, new ideas Int Clin Psychopharmacol 1993 8 suppl: 53–56
Jacobs BL, Fornal CA . Serotonin and behavior. A general hypothesis. In: Bloom FE, Kupfer DJ (eds) Psychopharmacology: The Fourth Generation of Progress Raven Press: New York 1995 pp 461–469
Pei Q, Leslie RA, Grahame-Smith DG, Zetterstrom TS . 5-HT efflux from rat hippocampus in vivo produced by 4-aminopyridine is increased by chronic lithium administration Neuroreport 1995 6: 716–720
Sharp T, Bramwell SR, Lambert P, Grahame-Smith DG . Effect of short- and long-term administration of lithium on the release of endogenous 5-HT in the hippocampus of the rat in vivo and in vitro Neuropharmacology 1991 30: 977–984
Treiser SL, Cascio CS, O’Donohue TL, Thoa NB, Jacobowitz DM, Kellar KJ . Lithium increases serotonin release and decreases serotonin receptors in the hippocampus Science 1981 213: 1529–1531
Baptista TJ, Hernandez L, Burguera JL, Burguera M, Hoebel BG . Chronic lithium administration enhances serotonin release in the lateral hypothalamus but not in the hippocampus in rats. A microdialysis study J Neural Transm Gen Sect 1990 82: 31–41
Goodwin GM . The effects of antidepressant treatments and lithium upon 5-HT1A receptor function Prog Neuropsychopharmacol Biol Psychiatry 1989 13: 445–451
Odagaki Y, Koyama T, Matsubara S, Matsubara R, Yamashita I . Effects of chronic lithium treatment on serotonin binding sites in rat brain J Psychiatr Res 1990 24: 271–277
Carli M, Reader TA . Regulation of central serotonin transporters by chronic lithium: an autoradiographic study Synapse 1997 27: 83–89
Carli M, Afkhami-Dastjerdian S, Reader TA . Effects of a chronic lithium treatment on cortical serotonin uptake sites and 5-HT1A receptors Neurochem Res 1997 22: 427–435
Artigas F, Sarrias MJ, Martinez E, Gelpi E, Alvarez E, Udina C . Increased plasma free serotonin but unchanged platelet serotonin in bipolar patients treated chronically with lithium Psychopharmacology 1989 99: 328–332
Price LH, Charney DS, Delgado PL, Heninger GR . Lithium treatment and serotoninergic function. Neuroendocrine and behavioral responses to intravenous tryptophan in affective disorder Arch Gen Psychiatry 1989 46: 13–19
Hotta I, Yamawaki S, Segawa T . Long-term lithium treatment causes serotonin receptor down-regulation via serotonergic presynapses in rat brain Neuropsychobiology 1986 16: 19–26
Cassidy F, Murry E, Carroll BJ . Tryptophan depletion in recently manic patients treated with lithium Biol Psychiatry 1998 43: 230–232
Chaouloff F, Gunn SH, Young JB . Serotonin does not mediate the adrenal catecholamine-releasing effect of acute lithium administration in rats Psychoneuroendocrinology 1992 17: 135–144
Lacaille JC, Cloutier S, Reader TA . Lithium reduced synaptic transmission and increased neuronal excitability without altering endogenous serotonin, norepinephrine and dopamine in rat hippocampal slices in vitro Prog Neuropsychopharmacol Biol Psychiatry 1992 16: 397–412
Manji HK, Hsiao JK, Risby ED, Oliver J, Rudorfer MV, Potter WZ . The mechanisms of action of lithium. I. Effects on serotoninergic and noradrenergic systems in normal subjects Arch Gen Psychiatry 1991 48: 505–512
Price LH, Charney DS, Delgado PL, Heninger GR . Lithium and serotonin function: implications for the serotonin hypothesis of depression Psychopharmacology 1990 100: 3–12
Collier D, Stöber G, Li T, Heils A, Catalano M, Di Gerlach JH et al . A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders Mol Psychiatry 1996 1: 453–460
Collier DA, Arranz MJ, Sham P, Battersby S, Vallada H, Gerlach JH et al . The serotonin transporter is a potential susceptibility factor for bipolar affective disorder Neuroreport 1996 7: 1675–1679
Rees M, Norton N, Jones I, McCandless F, Scourfield J, Gerlach JH et al . Association studies of bipolar disorder at the human serotonin transporter gene (hSERT; 5HTT) Mol Psychiatry 1997 2: 398–402
Bellivier F, Laplanche JL, Leboyer M, Feingold J, Bottos C, Gerlach JH et al . Serotonin transporter gene and manic depressive illness: an association study Biol Psychiatry 1997 41: 750–752
Mendes de Oliveira JR, Otto PA, Vallada H, Lauriano V, Elkis H, Gerlach JH et al . Analysis of a novel functional polymorphism within the promoter region of the serotonin transporter gene (5-HTT) in Brazilian patients affected by bipolar disorder and schizophrenia Am J Med Gen 1998 81: 225–227
Furlong RA, Ho L, Walsh C, Rubinsztein JS, Jain S, Gerlach JH et al . Analysis and meta-analysis of two serotonin transporter gene polymorphisms in bipolar and unipolar affective disorders Am J Med Gen 1998 81: 58–63
Hoehe MR, Wendel B, Grunewald I, Chiaroni P, Levy N, Morris-Gerlach JH et al . Serotonin transporter (5-HTT) gene polymorphisms are not associated with susceptibility to mood disorders Am J Med Gen 1998 81: 1–3
Esterling LE, Yoshikawa T, Turner G, Badner JA, Bengel D, Gershon ES, Berrettini WH, Detera-Wadleigh SD . Serotonin transporter (5-HTT) gene and bipolar affective disorder Am J Med Gen 1998 81: 37–40
Gutierrez B, Arranz MJ, Collier DA, Valles V, Guillamat R, Gerlach JH et al . Serotonin transporter gene and risk for bipolar affective disorder—an association study in a Spanish population Biol Psychiatry 1998 43: 843–847
Oruc L, Verheyen GR, Furac I, Jakovljevic M, Ivezic S, Gerlach JH et al . Association analysis of the 5-HT2C receptor and 5-HT transporter genes in bipolar disorder Am J Med Gen 1997 74: 504–506
Ewald H, Flint T, Degn B, Mors O, Kruse TA . A functional variant of the serotonin transporter gene in families with bipolar affective disorder J Affect Disord 1998 48: 135–144
Kelsoe J, Remick R, Sadovnick A, Kristbjarnarson H, Flodman P, Gerlach JH et al . Genetic linkage study of bipolar disorder and the serotonin transporter Am J Med Gen 1996 67: 215–217
Lenzinger E, Neumeister A, Praschak-Rieder N, Fuchs K, Gerhard E, Gerlach JH et al . Behavioral effects of tryptophan depletion in seasonal affective disorder associated with the serotonin transporter gene? Psychiatry Res 1999 85: 241–246
Mundo E, Walker M, Tims H, Macciardi F, Kennedy JL . Lack of linkage disequilibrium between serotonin transporter protein gene (SLC6A4) and bipolar disorder Am J Med Genet 2000 96: 379–383
Ospina-Duque J, Duque C, Carvajal-Carmona L, Ortiz-Barrientos D, Soto I, Gerlach JH et al . An association study of bipolar mood disorder (type I) with the 5-HTTLPR serotonin transporter polymorphism in a human population isolate from Colombia Neurosci Lett 2000 292: 199–202
Saleem Q, Ganesh S, Vijaykumar M, Reddy YC, Brahmachari SK, Jain S . Association analysis of 5HT transporter gene in bipolar disorder in the Indian population Am J Med Genet 2000 96: 170–172
Lesch K, Bengel D, Heils A, Sabol S, Greenberg B, Gerlach JH et al . Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region Science 1996 274: 1527–1530
Jorm AF, Prior M, Sanson A, Smart D, Zhang Y, Easteal S . Association of a functional polymorphism of the serotonin transporter gene with anxiety-related temperament and behavior problems in children: a longitudinal study from infancy to the mid-teens Mol Psychiatry 2000 5: 542–547
Greenberg BD, Li Q, Lucas FR, Hu S, Sirota LA, Gerlach JH et al . Association between the serotonin transporter promoter polymorphism and personality traits in a primarily female population sample Am J Med Genet 2000 96: 202–216
Gustavsson JP, Nothen MM, Jonsson EG, Neidt H, Forslund K, Gerlach JH et al . No association between serotonin transporter gene polymorphisms and personality traits Am J Med Genet 1999 88: 430–436
Kumakiri C, Kodama K, Shimizu E, Yamanouchi N, Okada S, Gerlach JH et al . Study of the association between the serotonin transporter gene regulatory region polymorphism and personality traits in a Japanese population Neuroscience Lett 1999 263: 205–207
Katsuragi S, Kunugi H, Sano A, Tsutsumi T, Isogawa K, Gerlach JH et al . Association between serotonin transporter gene polymorphism and anxiety-related traits Biol Psychiatry 1999 45: 368–370
Murakami F, Shimomura T, Kotani K, Ikawa S, Nanba E, Adachi K . Anxiety traits associated with a polymorphism in the serotonin transporter gene regulatory region in the Japanese J Hum Genet 1999 44: 15–17
Serretti A, Cusin C, Lattuada E, Di Bella D, Catalano M, Smeraldi E . Serotonin transporter gene (5-HTTLPR) is not associated with depressive symptomatology in mood disorders Mol Psychiatry 1999 4: 280–283
Rosenthal N, Mazzanti C, Barnett R, Hardin T, Turner E, Gerlach JH et al . Role of serotonin transporter promoter repeat length polymorphism (5-HTTLPR) in seasonality and seasonal affective disorder Mol Psychiatry 1998 3: 175–177
Ohara K, Nagai M, Suzuki Y, Ochiai M . Association between anxiety disorders and a functional polymorphism in the serotonin transporter gene Psychiatry Res 1998 81: 277–279
Klauck SM, Poustka F, Benner A, Lesch KP, Poustka A . Serotonin transporter (5-HTT) gene variants associated with autism? Hum Mol Genet 1997 6: 2233–2238
Cook EH Jr, Courchesne R, Lord C, Cox NJ, Yan S, Gerlach JH et al . Evidence of linkage between the serotonin transporter and autistic disorder Mol Psychiatry 1997 2: 247–250
Persico AM, Militerni R, Bravaccio C, Schneider C, Melmed R, Gerlach JH et al . Lack of association between serotonin transporter gene promoter variants and autistic disorder in two ethnically distinct samples Am J Med Genet 2000 96: 123–127
Ohara K, Suzuki Y, Ochiai M, Tsukamoto T, Tani K . A variable-number-tandem-repeat of the serotonin transporter gene and anxiety disorders Prog Neuropsychopharmacol Biol Psychiatry 1999 23: 55–65
Hamilton SP, Heiman GA, Haghighi F, Mick S, Klein DF, Gerlach JH et al . Lack of genetic linkage or association between a functional serotonin transporter polymorphism and panic disorder Psychiatr Genet 1999 9: 1–6
Sander T, Harms H, Lesch KP, Dufeu P, Kuhn S, Gerlach JH et al . Association analysis of a regulatory variation of the serotonin transporter gene with severe alcohol dependence Alcohol Clin Exp Res 1997 21: 1356–1359
Hammoumi S, Payen A, Favre JD, Balmes JL, Benard JY, Gerlach JH et al . Does the short variant of the serotonin transporter linked polymorphic region constitute a marker of alcohol dependence? Alcohol 1999 17: 107–112
Bellivier F, Szoke A, Henry C, Lacoste J, Bottos C, Nosten-Gerlach JH et al . Possible association between serotonin transporter gene polymorphism and violent suicidal behavior in mood disorders Biol Psychiatry 2000 48: 319–322
Gorwood P, Batel P, Ades J, Hamon M, Boni C . Serotonin transporter gene polymorphisms, alcoholism, and suicidal behavior Biol Psychiatry 2000 48: 259–264
Geijer T, Frisch A, Persson ML, Wasserman D, Rockah R, Gerlach JH et al . Search for association between suicide attempt and serotonergic polymorphisms Psychiatr Genet 2000 10: 19–26
Bligh-Glover W, Kolli TN, Shapiro-Kulnane L, Dilley GE, Friedman L, Gerlach JH et al . The serotonin transporter in the midbrain of suicide victims with major depression Biol Psychiatry 2000 47: 1015–1024
Malhotra AK, Goldman D, Mazzanti C, Clifton A, Breier A, Pickar D . A functional serotonin transporter (5-HTT) polymorphism is associated with psychosis in neuroleptic-free schizophrenics Mol Psychiatry 1998 3: 328–332
Bonnet-Brilhault F, Laurent C, Thibaut F, Campion D, Chavand O, Gerlach JH et al . Serotonin transporter gene polymorphism and schizophrenia: an association study Biol Psychiatry 1997 42: 634–636
Stober G, Jatzke S, Heils A, Jungkunz G, Fuchs E, Gerlach JH et al . Susceptibility for schizophrenia is not influenced by a functional insertion/deletion variant in the promoter of the serotonin transporter gene Eur Arch Psychiatry Clin Neurosci 1998 248: 82–86
Naylor L, Dean B, Pereira A, Mackinnon A, Kouzmenko A, Copolov D . No association between the serotonin transporter-linked promoter region polymorphism and either schizophrenia or density of the serotonin transporter in human hippocampus Molec Med 1998 4: 671–674
Rao D, Jonsson E, Paus S, Ganguli R, Nothen M, Nimgaonkar V . Schizophrenia and the serotonin transporter gene Psychiatr Genet 1998 8: 207–212
Hranilovic D, Schwab SG, Jernej B, Knapp M, Lerer B, Gerlach JH et al . Serotonin transporter gene and schizophrenia: evidence for association/linkage disequilibrium in families with affected siblings Mol Psychiatry 2000 5: 91–95
Tsai SJ, Hong CJ, Yu YW, Lin CH, Song HL, Gerlach JH et al . Association study of a functional serotonin transporter gene polymorphism with schizophrenia, psychopathology and clozapine response Schizophr Res 2000 44: 177–181
Serretti A, Lattuada E, Catalano M, Smeraldi E . Serotonin transporter gene not associated with psychotic symptomatology of mood disorders Psychiatry Res 1999 86: 59–65
Serretti A, Catalano M, Smeraldi E . Serotonin transporter gene is not associated with symptomatology of schizophrenia Schizophr Res 1999 35: 33–39
Heils A, Teufel A, Petri S, Stöber G, Riederer P, Gerlach JH et al . Allelic variation of human serotonin transporter gene expression J Neurochem 1996 66: 2621–2624
Lipp O, Mahieu B, Souery D, Serretti A, Cavallini C, Gerlach JH et al . Molecular genetics of bipolar disorders: implication for psychotropic drugs. Xth Congress of the European College of Neuropsychopharmacology 1997, Vienna, Austria
Serretti A, Lilli R, Lorenzi C, Gasperini M, Smeraldi E . Tryptophan hydroxylase gene and response to lithium prophylaxis in mood disorders J Psychiatr Res 1999 33: 371–377
Serretti A, Lilli R, Lorenzi C, Franchini L, DiBella D, Gerlach JH et al . Dopamine receptor D2, D4, GABAA alpha-1 subunit genes and response to lithium prophylaxis in mood disorders Psychiatry Res 1999 87: 7–19
Serretti A, Lilli R, Lorenzi C, Gasperini M, Smeraldi E . Dopamine receptor D3 gene and response to lithium prophylaxis in mood disorders Int J Neuropsychopharmacol 1998 1: 125–129
Serretti A, Lorenzi C, Lilli R, Smeraldi E . Serotonin receptor 2A, 2C, 1A genes and response to lithium prophylaxis in mood disorders J Psychiatr Res 2000 34: 89–98
Smeraldi E, Zanardi R, Benedetti F, Dibella D, Perez J, Catalano M . Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine Mol Psychiatry 1998 3: 508–511
Zanardi R, Serretti A, Rossini D, Franchini L, Cusin C, Gerlach JH et al . Factors affecting fluvoxamine antidepressant activity: influence of pindolol and 5-HTTLPR in delusional and nondelusional depression Biol Psychiatry (in press)
Zanardi R, Benedetti F, DiBella D, Catalano M, Smeraldi E . Efficacy of paroxetine in depression is influenced by a functional polymorphism within the promoter of serotonin transporter gene J Clin Psychopharmacol 2000 20: 105–107
Pollock BG, Ferrell RE, Mulsant BH, Mazumdar S, Miller M, Gerlach JH et al . Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression Neuropsychopharmacology 2000 23: 587–590
Benedetti F, Serretti A, Colombo C, Campori E, Barbini B, Di Gerlach JH et al . Influence of a functional polymorphism within the promoter of the serotonin transporter gene on the effects of total sleep deprivation in bipolar depression Am J Psychiatry 1999 156: 1450–1452
Greenberg BD, Tolliver TJ, Huang SJ, Li Q, Bengel D, Murphy DL . Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets Am J Med Gen 1999 88: 83–87
Bellivier F, Henry C, Szoke A, Schurhoff F, Nosten-Bertrand M, Gerlach JH et al . Serotonin transporter gene polymorphisms in patients with unipolar or bipolar depression Neurosci Lett 1998 255: 143–146
Flory JD, Manuck SB, Ferrell RE, Dent KM, Peters DG, Muldoon MF . Neuroticism is not associated with the serotonin transporter (5-HTTLPR) polymorphism Mol Psychiatry 1999 4: 93–96
Matsushita S, Muramatsu T, Kimura M, Shirakawa O, Mita T, Gerlach JH et al . Serotonin transporter gene regulatory region polymorphism and panic disorder Mol Psychiatry 1997 2: 390–392
Fuciarelli M, Vienna A, Paba E, Bastianini A, Sansonetti B, Capucci E et l . PI, GC, HP, and TF serum protein polymorphisms in Siena, Tuscany, Italy, with a review of data for Italy Am J Hum Biol 1997 9: 629–646
Maj M, Pirozzi R, Magliano L, Bartoli L . Long-term outcome of lithium prophylaxis in bipolar disorder: a 5-year prospective study of 402 patients at a lithium clinic Am J Psychiatry 1998 155: 30–35
Lattuada E, Serretti A, Cusin C, Gasperini M, Macciardi F, Smeraldi E . Symptomatologic analysis of psychotic and non-psychotic depression J Affect Disord 1999 54: 183–187
Serretti A, Lattuada E, Cusin C, Gasperini M, Smeraldi E . Clinical and demographical features of psychotic and nonpsychotic depression Compr Psychiatry 1999 40: 358–362
Cohen J . Statistical Power Analysis for the Behavioral Sciences Lawrence Erlbaum Associates: Hillsdale, New Jersey 1988
Risch N, Botstein D . A manic depressive history Nat Genet 1996 12: 351–353
Tsuang M, Faraone S . The Genetics of Mood Disorders The Johns Hopkins University Press: Baltimore 1990
Muller-Oerlinghausen B . Does effective lithium prophylaxis result in a symptom-free state of manic-depressive illness? Some thoughts on the fine-tuning of mood stabilization Compr Psychiatry 2000 41: 26–31
Page C, Benaim S, Lappin F . A long-term retrospective follow-up study of patients treated with prophylactic lithium carbonate Br J Psychiatry 1987 150: 175–179
Vestergaard P, Licht RW, Brodersen A, Rasmussen NA, Christensen H, Gerlach JH et al . Outcome of lithium prophylaxis—a prospective follow-up of affective disorder patients assigned to high and low serum lithium levels Acta Psychiatr Scand 1998 98: 310–315
Kulhara P, Basu D, Mattoo SK, Sharan P, Chopra R . Lithium prophylaxis of recurrent bipolar affective disorder: long-term outcome and its psychosocial correlates J Affect Disord 1999 54: 87–96
Tondo L, Baldessarini RJ, Hennen J, Floris G . Lithium maintenance treatment of depression and mania in bipolar I and bipolar II disorders Am J Psychiatry 1998 155: 638–645
Baldessarini RJ, Tondo L . Does lithium treatment still work? Evidence of stable responses over three decades Arch Gen Psychiatry 2000 57: 187–190
Souery D, Lipp O, Serretti A, Mahieu B, Rivelli SK, Gerlach JH et al . European Collaborative Project on Affective Disorders: Interactions between genetic and psychosocial vulnerability factors Psychiatr Genet 1998 8: 197–205
Endicott J, Spitzer R . A diagnostic interview: the schedule for affective disorders and schizophrenia Arch Gen Psychiatry 1978 35: 837–844
McGuffin P, Farmer A, Harvey I . A polydiagnostic application of operational criteria in studies of psychotic illness. Development and reliability of the OPCRIT system Arch Gen Psychiatry 1991 48: 764–770
American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders, 4th edn American Psychiatric Association: Washington DC 1994
Leckman JF, Sholomskas D, Thompson WD, Belanger A, Weissman MM . Best estimate of lifetime psychiatric diagnosis: a methodological study Arch Gen Psychiatry 1982 39: 879–883
Hamilton M . Development of a rating scale for primary depressive illness Br J Soc Clin Psychol 1967 6: 278–296
Young R, Biggs J, Ziegler V, Meyer D . A rating scale for mania: reliability, validity and sensitivity Br J Psychiatry 1978 133: 429–435
Frank E, Prien RF, Jarrett RB, Keller MB, Kupfer DJ, Gerlach JH et al . Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence Arch Gen Psychiatry 1991 48: 851–855
American Psychiatric Association . Practice guideline for the treatment of patients with bipolar disorder Am J Psychiatry 1994 151: 1–36
WMA . World Medical Association declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects JAMA 1997 277: 925–926
Gasperini M, Scherillo P, Manfredonia M, Franchini L, Smeraldi E . A study of relapses in subjects with mood disorder on lithium treatment Eur Neuropsychopharmacol 1993 3: 103–110
Franchini L, Gasperini M, Smeraldi E . A 24-month follow-up study of unipolar subjects: a comparison between lithium and fluvoxamine J Affect Disord 1994 32: 225–231
Lahiri DK, Nurnberger JIJ . A rapid non-enzimatic method for the preparation of HMW DNA from blood for RFLP studies Nucleic Acid Res 1991 19: 5444
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Serretti, A., Lilli, R., Mandelli, L. et al. Serotonin transporter gene associated with lithium prophylaxis in mood disorders. Pharmacogenomics J 1, 71–77 (2001). https://doi.org/10.1038/sj.tpj.6500006
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.tpj.6500006
Keywords
This article is cited by
-
The Role of Pharmacogenomics in Bipolar Disorder: Moving Towards Precision Medicine
Molecular Diagnosis & Therapy (2018)
-
Pharmacogenomics in the treatment of mood disorders: Strategies and Opportunities for personalized psychiatry
EPMA Journal (2017)
-
Lithium-responsive genes and gene networks in bipolar disorder patient-derived lymphoblastoid cell lines
The Pharmacogenomics Journal (2016)
-
Lithium in the treatment of bipolar disorder: pharmacology and pharmacogenetics
Molecular Psychiatry (2015)
-
Gene-expression differences in peripheral blood between lithium responders and non-responders in the Lithium Treatment-Moderate dose Use Study (LiTMUS)
The Pharmacogenomics Journal (2014)